Skip to main content

Klompas Neil A's Form 4 filing

Zymeworks Inc. (ZYME) · filed Mar 11, 2022

Accession no.
0000899243-22-010795
Filed
Mar 11, 2022
Trade date
Mar 10, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $20.5K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klompas Neil ACIK 0001761857Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 10, 2022Common SharesMOption exerciseAcquired+2,500$0.00F1$013,547Direct
Mar 10, 2022Common SharesMOption exerciseAcquired+2,708$0.00F2$016,255Direct
Mar 10, 2022Common SharesSSaleDisposed−2,979$6.88F4−$20,495.5213,276Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 10, 2022Common SharesMOption exerciseDisposed−2,500$0.00$02,500Direct
Mar 10, 2022Common SharesMOption exerciseDisposed−2,708$0.00$05,417Direct
Mar 10, 2022Common SharesAGrant or awardAcquired+200,000$0.00$0200,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020.

Referenced by the price of 1 transaction in Table I.

F2

Represents common shares issued upon vesting of one third of the RSUs granted on March 10, 2021.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.83 to $6.97, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)